DE112012006019T5 - Unterstützungsvorrichtung zur Diabetesbehandlung, Unterstützungsverfahren zur Diabetesbehandlung, Unterstützungsprogramm zur Diabetesbehandlung - Google Patents

Unterstützungsvorrichtung zur Diabetesbehandlung, Unterstützungsverfahren zur Diabetesbehandlung, Unterstützungsprogramm zur Diabetesbehandlung Download PDF

Info

Publication number
DE112012006019T5
DE112012006019T5 DE112012006019.9T DE112012006019T DE112012006019T5 DE 112012006019 T5 DE112012006019 T5 DE 112012006019T5 DE 112012006019 T DE112012006019 T DE 112012006019T DE 112012006019 T5 DE112012006019 T5 DE 112012006019T5
Authority
DE
Germany
Prior art keywords
blood sugar
meal
sugar level
unit
blood glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE112012006019.9T
Other languages
German (de)
English (en)
Inventor
c/o OMRON HEALTHCARE Co. Ltd. Tokita Muneo
c/o OMRON HEALTHCARE Co. Ltd. Nakajima Satoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omron Healthcare Co Ltd
Original Assignee
Omron Healthcare Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omron Healthcare Co Ltd filed Critical Omron Healthcare Co Ltd
Publication of DE112012006019T5 publication Critical patent/DE112012006019T5/de
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7278—Artificial waveform generation or derivation, e.g. synthesizing signals from measured signals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/486—Biofeedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4866—Evaluating metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Signal Processing (AREA)
  • Psychiatry (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Business, Economics & Management (AREA)
  • Epidemiology (AREA)
  • Business, Economics & Management (AREA)
  • Primary Health Care (AREA)
DE112012006019.9T 2012-03-12 2012-11-12 Unterstützungsvorrichtung zur Diabetesbehandlung, Unterstützungsverfahren zur Diabetesbehandlung, Unterstützungsprogramm zur Diabetesbehandlung Pending DE112012006019T5 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012054382A JP5900044B2 (ja) 2012-03-12 2012-03-12 糖尿病治療支援装置、糖尿病治療支援方法、糖尿病治療支援プログラム
JP2012-054382 2012-03-12
PCT/JP2012/079284 WO2013136585A1 (ja) 2012-03-12 2012-11-12 糖尿病治療支援装置、糖尿病治療支援方法、糖尿病治療支援プログラム

Publications (1)

Publication Number Publication Date
DE112012006019T5 true DE112012006019T5 (de) 2014-12-18

Family

ID=49160538

Family Applications (1)

Application Number Title Priority Date Filing Date
DE112012006019.9T Pending DE112012006019T5 (de) 2012-03-12 2012-11-12 Unterstützungsvorrichtung zur Diabetesbehandlung, Unterstützungsverfahren zur Diabetesbehandlung, Unterstützungsprogramm zur Diabetesbehandlung

Country Status (5)

Country Link
US (1) US9131903B2 (https=)
JP (1) JP5900044B2 (https=)
CN (1) CN104168829B (https=)
DE (1) DE112012006019T5 (https=)
WO (1) WO2013136585A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111879948A (zh) 2013-10-17 2020-11-03 综合医院公司 鉴定响应于用于自身免疫性疾病的治疗的受试者的方法以及用于治疗该疾病的组合物
US20170316176A1 (en) * 2014-12-25 2017-11-02 Hitachi, Ltd. Device for analyzing insulin secretion ability, system for analyzing insulin secretion ability provided with same, and method for analyzing insulin secretion ability
KR101807854B1 (ko) * 2016-01-29 2017-12-12 주식회사 아이센스 임신성 당뇨병 환자를 위한 식사 시간 정보의 제공 방법
US11039986B2 (en) 2016-02-25 2021-06-22 Samsung Electronics Co., Ltd. Chronotherapeutic dosing of medication and medication regimen adherence
WO2017187212A1 (en) * 2016-04-28 2017-11-02 77 Elektronika Müszeripari Kft. Data processing method for blood glucose measuring, blood glucose meter, blood glucose measurement system, and computer program and data carrier therefor
EP3457136A4 (en) * 2016-05-13 2020-02-26 Eiken Kagaku Kabushiki Kaisha METHOD FOR CALCULATING THE RELATIONSHIP OF MEASURING OBJECT SUBSTANCE TO COMPARATIVE OBJECT SUBSTANCE, PROGRAM, STORAGE MEDIUM AND DEVICE
WO2018001853A1 (en) * 2016-06-30 2018-01-04 Novo Nordisk A/S Regimen adherence measure for insulin treatment based on glucose measurements and insulin pen data
CN108283486B (zh) * 2017-01-09 2021-04-09 腾讯科技（深圳）有限公司 测量数据的处理方法及装置
JP7149053B2 (ja) * 2017-04-25 2022-10-06 株式会社田中金属製作所 糖尿病予防又は改善用液状物
AU2019427253A1 (en) * 2019-01-28 2021-07-15 Medibeacon Inc. Systems and methods for home transdermal GFR monitoring
CN115004310A (zh) * 2019-11-25 2022-09-02 雅培糖尿病护理公司 用于生理参数分析的方法、设备和系统
CN113128301A (zh) * 2019-12-31 2021-07-16 苏州三六零智能安全科技有限公司 视频鉴黄方法、系统、存储介质及其计算机设备
WO2025064603A1 (en) * 2023-09-21 2025-03-27 Abbott Diabetes Care Inc. Methods, devices, and systems for adjusting laboratory hba1c values

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001245900A (ja) 2000-03-02 2001-09-11 Arkray Inc グラフおよびグラフの表示方法並びにグラフ表示装置
JP4273036B2 (ja) * 2004-05-12 2009-06-03 中 奥村 投薬支援プログラム、投薬支援装置、投薬支援プログラムを記録した記録媒体及び投薬支援システム
US20080045819A1 (en) 2004-07-21 2008-02-21 Matsushita Electric Industrial Co., Ltd. Blood-Sugar Level Management System
US20070016449A1 (en) * 2005-06-29 2007-01-18 Gary Cohen Flexible glucose analysis using varying time report deltas and configurable glucose target ranges
US7824333B2 (en) * 2006-03-31 2010-11-02 Lifescan, Inc. Diabetes management methods and systems
JP2008213098A (ja) * 2007-03-06 2008-09-18 Mitsubishi Heavy Ind Ltd 割り出しテーブル
JP4889116B2 (ja) 2007-03-20 2012-03-07 旭化成ファーマ株式会社 肝疾患における正確な血糖コントロール状態および肝機能を算出する方法
US20080235053A1 (en) * 2007-03-20 2008-09-25 Pinaki Ray Communication medium for diabetes management
EP1980851A3 (en) * 2007-03-30 2014-03-12 Tanita Corporation Blood sugar condition estimation method and apparatus
SG159459A1 (en) * 2008-08-15 2010-03-30 Lifescan Scotland Ltd Analyte testing method and system
US20100330598A1 (en) * 2009-06-26 2010-12-30 Roche Diagnostics Operations, Inc. METHOD, SYSTEM, AND COMPUTER PROGRAM PRODUCT FOR PROVIDING BOTH AN ESTIMATED TRUE MEAN BLOOD GLUCOSE VALUE AND ESTIMATED GLYCATED HEMOGLOBIN (HbA1C) VALUE FROM STRUCTURED SPOT MEASUREMENTS OF BLOOD GLUCOSE
JP2012024439A (ja) * 2010-07-27 2012-02-09 Seiko Epson Corp 血糖値予測システム

Also Published As

Publication number Publication date
JP5900044B2 (ja) 2016-04-06
JP2013188240A (ja) 2013-09-26
US20150038816A1 (en) 2015-02-05
WO2013136585A9 (ja) 2014-07-31
CN104168829B (zh) 2016-12-07
US9131903B2 (en) 2015-09-15
CN104168829A (zh) 2014-11-26
WO2013136585A1 (ja) 2013-09-19

Similar Documents

Publication Publication Date Title
DE112012006019T5 (de) Unterstützungsvorrichtung zur Diabetesbehandlung, Unterstützungsverfahren zur Diabetesbehandlung, Unterstützungsprogramm zur Diabetesbehandlung
Resnick et al. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults
Derr et al. Is HbA1c affected by glycemic instability?
Van den Akker et al. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases
EP2470913B1 (de) Kalibrierverfahren zur prospektiven Kalibrierung eines Messgeräts, Computerprogramm und Messgerät
Allison et al. Body mass index and all-cause mortality among people age 70 and over: the Longitudinal Study of Aging
Holdgate et al. Comparison of a verbal numeric rating scale with the visual analogue scale for the measurement of acute pain
DE60133667T2 (de) Mit kommentareingabefunktion ausgestattete messvorrichtung
DE602004002727T2 (de) Gesundheitsüberwachungsgerät
DE112009003803T5 (de) Elektronisches Blutdruckmessgerät und Verfahren zur Blutdruckmessung
US11793471B2 (en) Method and system for monitoring a diabetes treatment plan
JP2007304088A (ja) 糖尿病管理方法及びシステム
DE112012003248T5 (de) Vorrichtung zur Analyse von Urinbestandteilen und Verfahren zur Analyse von Urinbestandteilen
Bhowmik et al. Obesity and associated type 2 diabetes and hypertension in factory workers of Bangladesh
Deane et al. Relationship between self-report and log data estimates of information system usage
Hansen et al. Clinical significance: An overview of methods
Hijazi et al. Perception of the risk of stroke and the risks and benefits of oral anticoagulation for stroke prevention in patients with atrial fibrillation: a cross-sectional study
Mallinson et al. Responsiveness, minimal detectable change, and minimally clinically important differences for the disorders of consciousness scale
Eastman et al. Use of the GlucoWatch® biographer in children and adolescents with diabetes
Alemi et al. Time-between control charts for monitoring asthma attacks
Zinman et al. Cooling detection thresholds in the assessment of diabetic sensory polyneuropathy: comparison of CASE IV and Medoc instruments
Delaney et al. Pitfalls in the measurement of the nocturnal blood pressure dip in adolescents with type 1 diabetes
Oakley et al. A validation study of the Daily Activities Questionnaire: An activities of daily living assessment for people with Alzheimer's disease
Praxel et al. Improving the efficiency and effectiveness of performing the diabetic foot exam
Baumeister et al. Spoilt for choice–evaluation of two different scoring systems for early hand eczema in teledermatological examinations

Legal Events

Date Code Title Description
R012 Request for examination validly filed
R016 Response to examination communication